Document:

<PAGE>   1

                                                                   EXHIBIT 10.40

September 15, 1999

TO:      Philip Teplitzky
FR:      Kathryn Creech
RE:      Your Employment with VitaminShoppe.com.

It is with pleasure that I confirm our offer to have you join VitaminShoppe.com
(the "Company") as Chief Technology Officer. You will report to me with
responsibility for leading the development and implementation of the e-commerce
infrastructure necessary to support our business. You will be a member of our
senior management team and participate in the development of cross-functional
strategic initiatives critical to the growth of VitaminShoppe.com. Your start
date will be September 30, 1999.

In consideration for your services, you will receive an annual salary of
$250,000. You will also receive a one-time start up bonus of $50,000. Your
compensation will be reviewed annually. As a senior employee with the Company,
you will also be eligible to participate in all Company - health and welfare
benefit programs available to executives of the Company. You will receive
vacation and sick leave in accordance with standard Company policies. In
addition, you will be eligible for participation in performance bonus programs,
if any, developed by the Company, with bonuses to be awarded at the sole
discretion of the Board of Directors.

In the event your employment with the Company is terminated for reasons other
than Good Cause (as defined in the attached Stock Option Plan (the "Option
Plan")), you will be entitled to receive monthly severance payments from the
Company, based on your monthly salary at the time of termination, which payments
will terminate at the later of (i) twelve months from your Start Date or (ii)
six months from the date of your termination. If you terminate your employment
with the Company with Good Reason (as defined in the Option Plan) following a
Qualifying Business Combination (as defined in the Option Plan), you will also
be entitled to receive the severance payments described in the preceding
sentence. Your medical benefits provided by the Company will continue in effect
during any period in which you are receiving severance payments. In the event
your employment with the Company is terminated for Good Cause, your rights to
receive compensation and benefits will terminate on the date of the termination
of your employment.

In addition to the compensation described above, you will be granted options
("Options") to purchase 180,000 shares of the Company's common stock
(post-split, excluding the conversion of Series A Convertible Preferred). The
exercise price is $9.15 per share. The Options will vest over a period of three
years, with one-third vesting on each of the first three anniversaries of your
Start Date. The Options will be granted pursuant to, and in accordance with, the
Option Plan and a Stock Option Agreement to be executed by you and the Company.

As a condition of your employment, you will be required to execute the Company's
standard Confidentiality, Non-Competition and Non-Solicitation Agreement, a copy
of which is attached hereto.

I hope this letter addresses the key issues relating to your employment by
VitaminShoppe.com. We are very excited to have you join our team and about the
prospects for our business.

/s/ Kathryn Creech                              /s/ Philip Teplitzky
------------------------------------            --------------------------------
Kathryn Creech                                  Philip Teplitzky
President and CEO
VitaminShoppe.com

cc:  Jeff Horowitz, VitaminShoppe.com
     Howard Romanow, FdG Associates<PAGE>   1
                                                                   EXHIBIT 10.41

Date:  October 6, 1999

TO:  Ann Sardini
FR:  Kathryn Creech
RE:  Your Employment with VitaminShoppe.com

It is with pleasure that I confirm our offer to have you join VitaminShoppe.com
(the "Company") as CFO, with a start date of October 18, 1999 (the "Start
Date"). You will report to me, with dotted line reporting to the Company's
Board of Directors, with responsibility for building and managing the Company's
financial and administrative organizations, including responsibility for
supporting the Company's business development, marketing and growth efforts,
managing the finance- and operations-related elements of the Company's
relationship with Vitamin Shoppe Industries and ensuring the integration of the
Company's financial systems with its internet infrastructure.

In consideration for your services, you will receive an annual salary of
$250,000. You will also receive a one-time start up bonus of $25,000. Your
compensation will be reviewed annually. As a senior employee with the Company,
you will also be eligible to participate in all Company health and welfare
benefit programs available to executives of the Company. You will receive
vacation and sick leave in accordance with standard Company policies. In
addition, you will be eligible for participation in performance bonus programs
(either cash or equity), if any, developed by the Company, with bonuses to be
awarded at the sole discretion of the Board of Directors.

In the event your employment with the Company is terminated for reasons other
than Good Cause (as defined in the attached Stock Option Plan (the "Option
Plan")), you will be entitled to receive monthly severance payments from the
Company, based on your monthly salary at the time of termination, which
payments will terminate at the later of (i) twelve months from your Start Date
or (ii) six months from the date of your termination. If you terminate your
employment with the Company with Good Reason (as defined in the Option Plan)
following a Qualifying Business Combination (as defined in the Option Plan),
you will also be entitled to receive the severance payments described in the
preceding sentence. Your medical benefits provided by the Company will continue
in effect during any period in which you are receiving severance payments. In
the event your employment with the Company is terminated for Good Cause, your
rights to receive compensation and benefits will terminate on the date of the
termination of your employment.

In addition to the compensation described above, you will be granted options
(the "Options") to purchase 200,000 shares of the Company's common stock, at an
exercise price of $9.15. The Options will vest over a period of three years,
with one-third vesting on each of the first three anniversaries of your Start
Date. The Options will be granted pursuant to, and in accordance with, the
Option Plan and a Stock Option Agreement to be executed by you and the Company.

As a condition of your employment, you will be required to execute the
Company's standard Confidentiality, Non-Competition and Non-Solicitation
Agreement, a copy of which is attached hereto.

I hope this letter addresses the key issues relating to your employment by
VitaminShoppe.com. We are very excited to have you join our team and about the
prospects for our business.

Kathryn Creech                                    Ann Sardini
------------------------                          ------------------------
Kathryn Creech                                    Ann Sardini
President and CEO
VitaminShoppe.com<PAGE>   1
                                                                  EXHIBIT 10.42

                        SEPARATION AND RELEASE AGREEMENT

     Separation and Release Agreement dated as of January 17, 2000, between
VitaminShoppe.com, Inc., a Delaware corporation (the "Company"), and Kathryn
Creech, an individual ("Creech").

     The Company and Creech desire to provide for the terms on which Creech's
employment by the Company will terminate.

     The parties hereto, intending to be legally bound, hereby agree as follows:

     SECTION 1. Termination. Creech's employment by the Company is terminated,
effective as of the date hereof. As a result of that termination, Creech will
hold no office or position, and will not be employed by, the Company. Creech
agrees and acknowledges that she will no longer serve in the positions of
President and Chief Executive Officer of the Company and that she has resigned
from the Board of Directors of the Company effective as of the date hereof.

     SECTION 2. SEVERANCE PAYMENTS; OPTIONS.

     2.1 Severance. Creech will receive from the Company the severance payments
and benefits to which she is entitled pursuant to Section 4(c) of the Employment
and Noncompetition Agreement between the Company and her dated as of June 14,
1999 (the "Employment Agreement "); provided, that such severance payments shall
not be made quarterly but shall be made by the Company to Creech on the
following dates in the amounts set forth opposite such dates, in full
satisfaction of all amounts payable by the Company to Creech under the
Employment Agreement:

                   DATE                                        AMOUNT

             February 17, 2000                              $8,333.33
             March 17, 2000                                 $8,333.33
             April 17, 2000                                 $208,333.33
             July 17, 2000                                  $24,999.99
             September 14, 2000                             $50,000.00
             October 17, 2000                               $24,999.99
             December 14, 2000                              $50,000.00
             January 17, 2001                               $24,999.99
             March 14, 2001                                 $50,000.00
             April 17, 2001                                 $24,999.99
             June 14, 2001                                  $65,307.90

<PAGE>   2

Creech acknowledges and agrees that this Agreement shall be the exclusive basis
on which she is entitled to receive any compensation or benefits of any kind
from the Company. All payments made by the Company to Creech hereunder shall be
subject to all applicable federal and state withholding taxes.

     2.2 Stock Options. Creech currently holds fully vested options to acquire
130,815 shares of the Company's Class A Common Stock at $3.82 per share granted
under the Company's Stock Option Plan for Employees effective as of June 14,
1999 (the "Plan") and the Nonqualified Stock Option Agreement between the
Company and Creech made as of July 1, 1999, effective as of June 14, 1999 (the
"Option Agreement") and no other vested options or equity securities of the
Company. In consideration for her entry into this agreement and the releases
given by her hereunder, the Company hereby agrees to accelerate to today the
vesting of options to purchase an additional 50,000 shares of the Company's
Class A Common Stock at $3.82 per share granted to her under the Plan and the
Option Agreement. Creech acknowledges that all other options and rights to
purchase securities of the Company under the Employment Agreement, any option
agreement with the Company or any other arrangement with the Company remain
unvested and lapse as of the date hereof and that she will have no further claim
with respect thereto.

     SECTION 3. OFFICE/EQUIPMENT.

     3.1 Use of Office. The Company shall provide Creech with office space for
up to six months from the date hereof (or, if earlier, until she obtains new
employment), which shall not be in the Company's premises; provided that the
Company shall not be required to pay more than $2,500 per month for such office
space.

     3.2 Equipment. The Company hereby transfers to Creech, on an "as is" basis
without representation or warranty the Company's personal laptop computer
currently in her possession; provided that, prior to such transfer Creech shall
provide the Company with access to such laptop computer to enable the Company to
delete any and all information, data and files stored on such laptop computer as
the Company shall in its sole discretion elect to delete.

     SECTION 4. INDEMNIFICATION.

     To the extent permitted by law, the Company shall indemnify Creech with
respect to matters arising from her service as a director or officer or employee
of the Company as provided by the Company's Articles of Incorporation and
By-Laws as currently in effect.

     SECTION 5. MUTUAL RELEASES.

     (a) In consideration of the acceleration of additional stock options, the
other benefits conferred by this agreement and for other valuable consideration,
the receipt and adequacy of which are hereby acknowledged, Creech hereby
releases and forever discharges the Company and its subsidiaries, and their
respective past, present and future affiliates, stockholders, officers,
directors, employees, agents, and controlling persons, and the respective heirs,
administrators, successors and

                                       2
<PAGE>   3

assigns of each of the foregoing (each, a "Releasee"), of and from any and all
manner of action or actions, cause or causes of action, in law or in equity,
suits, debts, contracts, agreements, promises, liability, claims, demands,
damages, loss, cost or expense, of any nature whatsoever, known or unknown to
her, fixed or contingent, choate or inchoate, which Creech ever had, now has or
may have at any time arising out of or relating to Creech's employment with, or
status as a director or officer of, the Company or the termination of such
employment or status (or any promise or agreement made or entered into, or any
action taken or omitted, in connection with such employment, status or
termination), including, but not limited to, those arising under the federal
Civil Rights Acts of 1866, 1871, 1964 and 1971, as amended, the Age
Discrimination in Employment Act of 1967, as amended by, inter alia, the Older
Workers Benefit Protection Act of 1990, the Americans with Disabilities Act of
1990, the Employee Retirement Income Security Act of 1974 or any other federal,
state or local statute or principle of common law. Creech shall refrain from
asserting any matter released hereby against any Releasee in any manner,
including, but not limited to, by way of counterclaim, offset or defense and
shall actively resist any effort to assert on its behalf any such matter. Creech
shall indemnify and hold harmless each Releasee from and against all losses,
liabilities, claims, damages and expenses (including costs of investigation and
defense and reasonable attorneys' fees), arising directly or indirectly from or
in connection with the assertion by or on behalf of Creech of any claim or other
matter released pursuant to this paragraph.

     Notwithstanding anything contained herein to the contrary, there is and
shall be excepted from the within and foregoing release and discharge any and
all of the following: any and all of the obligations of the Company under this
Agreement; and any and all rights which Creech may have as an owner of Common
Stock and/or Options.

     (b) For valuable consideration, the receipt and adequacy of which are
hereby acknowledged, the Company hereby releases and forever discharges Creech
and her heirs, administrators, executors, agents, representatives, successors
and assigns (each, a "Creech Releasee"), of and from any and all manner of
action or actions, cause or causes of action, in law or in equity, suits, debts,
contracts, agreements, promises, liability, claims, demands, damages, loss, cost
or expense, of any nature whatsoever, known or unknown to the Company, fixed or
contingent, choate or inchoate, which the Company ever had, now has or may have
at any time arising out of or relating to Creech's employment or status as a
director or officer or the termination of such employment or status (or any
promise or agreement made or entered into, or any action taken or omitted, in
connection with such employment, status or termination). The Company shall
refrain from asserting any matter released hereby against any Creech Releasee in
any manner, including, but not limited to, by way of counterclaim, offset or
defense and shall actively resist any effort to assert on its behalf any such
matter. The Company shall indemnify and hold harmless each Creech Releasee from
and against all losses, liabilities, claims, damages and expenses (including
costs of investigation and defense and reasonable attorneys' fees), arising
directly or indirectly from or in connection with the assertion by or on behalf
of the Company of any claim or other matter released pursuant to this paragraph.
                                       3

<PAGE>   4

     Notwithstanding anything contained herein to the contrary, there is and
shall be excepted from the within and foregoing release and discharge any and
all of the following: any and all of the obligations of Creech under this
Agreement.

     SECTION 6. NO DISPARAGEMENT. The Company shall not , directly or
indirectly, disparage or impugn the reputation of Creech. Creech shall not,
directly or indirectly, disparage or impugn the reputation of the Company, or
any of its shareholders, directors, officers, employees or agents. Creech hereby
confirms that she does not intend to and shall not, directly or indirectly, make
or deliver to the Company any statement for inclusion (or that the Company might
be required to include or refer to) in the Company's proxy statement or any
filing by the Company with the Securities and Exchange Commission.

     SECTION 7. MISCELLANEOUS.

     7.1 Governing Law. This Agreement shall be construed in accordance with and
governed by the laws of the State of New York, without regard to any conflicts
of laws principles thereof that would call for the application of the laws of
any other jurisdiction. Any action or proceeding seeking to enforce any
provision of, or based on any right arising out of, this Agreement may be
brought against either of the parties hereto in the courts of the State of New
York, or if it has or can acquire jurisdiction, in the United States District
Court for the Southern District of New York, and each of the parties hereto
hereby consents to the jurisdiction of such courts (and of the appropriate
appellate courts) in any such action or proceeding and waives any objection to
venue laid therein. Process in any action or proceeding referred to in the
preceding sentence may be served on any party anywhere in the world, whether
within or without the State of New York.

     7.2 Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original and all of which, when
taken together, shall constitute one and the same agreements.

     7.3 Notices. All notices, demands, requests or other communications which
may be or are required to be given, served or sent by any party to any other
party pursuant to this Agreement shall be in writing and shall be mailed by
first class, registered or certified mail, return receipt requested, postage
prepaid, or transmitted by hand delivery (including delivery by courier), or
facsimile transmission, addressed as follows (or to such other addresses as a
party may specify as to itself by notice to the other):

                  If to the Company:

                           VitaminShoppe.com, Inc.
                           444 Madison Avenue, Suite 802
                           New York, New York 10022
                           Attention:  President and Chief Executive Officer
                           Facsimile:

                                      4
<PAGE>   5

                           with copies to:

                           Kaye, Scholer, Fierman, Hays & Handler, LLP
                           425 Park Avenue
                           New York, New York 10022
                           Attention: Nancy Fuchs, Esq.
                           Andrea Christensen, Esq.
                           Facsimile: (212) 836-8689

                           If to the Executive:

                           Kathryn Creech
                           31 Copper Beech Road
                           Greenwich, Connecticut 06830
                           Facsimile:       (212) 953-0910

                           with a copy to:

                           Louis L. Broudy, Esq.
                           Broudy & Associates, P.C.
                           230 Park Avenue, Suite 2400
                           New York, New York 10169
                           Facsimile:       (212) 490-3434

     7.4 Binding Nature of Agreement; Successors and Assigns. This Agreement
shall be binding upon and inure to the benefit of the parties hereto and their
respective heirs, personal representatives, successors and permitted assigns as
provided herein.

     7.5 Entire Agreement. This Agreement contains the entire agreement and
understanding among the parties hereto with respect to the subject matter
hereof, and supersedes all prior and contemporaneous agreements, understandings,
inducements and conditions, express or implied, oral or written, of any nature
whatsoever with respect to the subject matter hereof. The express terms hereof
control and supersede any course of performance and/or usage of trade
inconsistent with any of the terms hereof. This Agreement may not be modified or
amended other than by an agreement in writing.

     7.6 Indulgences, Not Waivers. Neither the failure nor any delay on the part
of a party to exercise any right, remedy, power or privilege under this
Agreement shall operate as a waiver thereof, nor shall any single or partial
exercise of any right, remedy, power or privilege preclude any other or further
exercise of the same or of any other right, remedy, power or privilege, nor
shall any waiver of any right, remedy, power of privilege with respect to any
occurrence be construed as a waiver of such right, remedy, power or privilege
with respect to any other occurrence. No waiver shall be effective unless it is
in writing and signed by the party asserted to have granted such waiver.

                                       5

<PAGE>   6

     7.7 Confidentiality. Creech shall keep the terms of this Agreement
confidential and she will not hereafter disclose any information concerning the
Company and/or this Agreement to anyone except her attorneys, accountants, tax
and financial advisors; except that she may repeat the statements made in the
press release issued by the Company with respect thereto on January 18, 2000
(which statements she authorized). The Company shall keep the terms of this
Agreement confidential and not hereafter disclose any information concerning
this Agreement to anyone except its attorneys, accountants, and tax and
financial advisors; except that the Company may make any disclosure regarding
the terms of this Agreement (including regarding the amounts payable to Creech
and the options accelerated hereunder) that it is advised by counsel is required
to be made under the Securities Exchange Act of 1934 (and the rules promulgated
thereunder) and any other applicable securities laws, and shall file this
Agreement as an exhibit to a report filed by the Company with the Securities and
Exchange Commission under the Securities Exchange Act of 1934, as amended.

     7.8 Independent Judgment; Revocation. The Company and Creech have each been
represented and advised by counsel in connection with the negotiation, execution
and delivery of this Agreement, have exercised independent judgment in
connection therewith, and have not relied on any statement, promise,
representation or warranty not expressly set forth in this Agreement. Creech may
revoke this agreement by written notice given to the Company within seven
calendar days after the date on which this Agreement is executed by Creech; if
so revoked, this agreement shall be of no effect. Creech hereby waives the
benefit of any longer revocation or review period to which she may be entitled
under any applicable law.

                                              VITAMINSHOPPE.COM, INC.

                                              By: /s/ Jeffrey J. Horowitz
                                                      --------------------------
                                              Name:   Jeffrey J. Horowitz
                                              Title:

      /s/ Kathryn H. Creech
          -------------------
          Kathryn Creech

                                       6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00005-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00005-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00005-of-00352.parquet"}]]